Multiple Indian pharma giants enter the semaglutide market with affordable generic versions for diabetes and weight management, intensifying competition and improving accessibility.
Semaglutide's role in controlling blood sugar involves slowing down digestion and reducing appetite, which makes a person feel fuller and potentially leads to lower caloric intake